Azenta, Inc. (AZTA)
NASDAQ: AZTA · Real-Time Price · USD
32.05
+1.45 (4.74%)
Oct 15, 2025, 4:00 PM EDT - Market closed
Azenta Revenue
Azenta had revenue of $143.94M in the quarter ending June 30, 2025, a decrease of -0.24%. This brings the company's revenue in the last twelve months to $668.82M, up 12.46% year-over-year. In the fiscal year ending September 30, 2024, Azenta had annual revenue of $656.32M, down -1.32%.
Revenue (ttm)
$668.82M
Revenue Growth
+12.46%
P/S Ratio
2.22
Revenue / Employee
$202,673
Employees
3,300
Market Cap
1.47B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 656.32M | -8.75M | -1.32% |
Sep 30, 2023 | 665.07M | 109.57M | 19.73% |
Sep 30, 2022 | 555.50M | 41.80M | 8.14% |
Sep 30, 2021 | 513.70M | 125.17M | 32.21% |
Sep 30, 2020 | 388.54M | 54.36M | 16.27% |
Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 92.15B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
AZTA News
- 20 hours ago - Azenta to Host Investor Day at its Biorepository Facility in Indianapolis, Indiana - PRNewsWire
- 2 months ago - Azenta, Inc. (AZTA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Azenta Reports Third Quarter Results for Fiscal 2025, Ended June 30, 2025; Reiterates Full Year Fiscal 2025 Guidance - PRNewsWire
- 2 months ago - Azenta Life Sciences Partners with Frenova, a Division of Fresenius Medical Care, and Nephronomics to Advance Genomic Research in Nephrology - PRNewsWire
- 2 months ago - Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care - PRNewsWire
- 2 months ago - Azenta to Participate in 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference - PRNewsWire
- 3 months ago - Azenta Announces Fiscal 2025 Third Quarter Earnings Conference Call and Webcast - PRNewsWire
- 5 months ago - Azenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy Development - PRNewsWire